Form 4 for NTLA Intellia Therapeutics, Inc.
Accepted 2024-07-03 00:00:00 ET · period of report 2024-07-01 · accession 0000950170-24-081259 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-03 | 2024-07-01 | NTLA | Clark Eliana | EVP, Chief Technical Off | S - Sale | $22.93 | -405 | 71.5K | -0.6% | -$9,287 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-01 | S | D | 405 | $22.93 | 71,470 | D | — | — |